Menu
GWAS Study

A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.

Miyagawa T, Khor SS, Toyoda H et al.

30266950 PubMed ID
GWAS Study Type
2417 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MT
Miyagawa T
KS
Khor SS
TH
Toyoda H
KT
Kanbayashi T
IA
Imanishi A
SY
Sagawa Y
KN
Kotorii N
KT
Kotorii T
AY
Ariyoshi Y
HY
Hashizume Y
OK
Ogi K
HH
Hiejima H
KY
Kamei Y
HA
Hida A
MM
Miyamoto M
IA
Ikegami A
WY
Wada Y
TM
Takami M
HY
Higashiyama Y
MR
Miyake R
KH
Kondo H
FY
Fujimura Y
TY
Tamura Y
TY
Taniyama Y
ON
Omata N
TY
Tanaka Y
MS
Moriya S
FH
Furuya H
KM
Kato M
KY
Kawamura Y
OT
Otowa T
MA
Miyashita A
KH
Kojima H
SH
Saji H
SM
Shimada M
YM
Yamasaki M
KT
Kobayashi T
MR
Misawa R
SY
Shigematsu Y
KR
Kuwano R
ST
Sasaki T
IJ
Ishigooka J
WY
Wada Y
TK
Tsuruta K
CS
Chiba S
TF
Tanaka F
YN
Yamada N
OM
Okawa M
KK
Kuroda K
KK
Kume K
HK
Hirata K
UN
Uchimura N
ST
Shimizu T
IY
Inoue Y
HY
Honda Y
MK
Mishima K
HM
Honda M
TK
Tokunaga K
Chapter II

Abstract

Summary of the research findings

Essential hypersomnia (EHS) is a lifelong disorder characterized by excessive daytime sleepiness without cataplexy. EHS is associated with human leukocyte antigen (HLA)-DQB1*06:02, similar to narcolepsy with cataplexy (narcolepsy). Previous studies suggest that DQB1*06:02-positive and -negative EHS are different in terms of their clinical features and follow different pathological pathways. DQB1*06:02-positive EHS and narcolepsy share the same susceptibility genes. In the present study, we report a genome-wide association study with replication for DQB1*06:02-negative EHS (408 patients and 2247 healthy controls, all Japanese). One single-nucleotide polymorphism, rs10988217, which is located 15-kb upstream of carnitine O-acetyltransferase (CRAT), was significantly associated with DQB1*06:02-negative EHS (P = 7.5 × 10-9, odds ratio = 2.63). The risk allele of the disease-associated SNP was correlated with higher expression levels of CRAT in various tissues and cell types, including brain tissue. In addition, the risk allele was associated with levels of succinylcarnitine (P = 1.4 × 10-18) in human blood. The leading SNP in this region was the same in associations with both DQB1*06:02-negative EHS and succinylcarnitine levels. The results suggest that DQB1*06:02-negative EHS may be associated with an underlying dysfunction in energy metabolic pathways.

119 Japanese ancestry cases, 1,582 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

2417
Total Participants
GWAS
Study Type
Yes
Replicated
283 Japanese ancestry cases, 433 Japanese ancestry controls
Replication Participants
East Asian
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.